CERVARIX
Bivalent HPV L1 protein (types 16, 18) · HPV
Health Canada DIN 02342227. Check the product and formulation on your record before using a schedule.
Plan doses for this product →At a glance
- Brand
- CERVARIX
- DIN
02342227- Vaccine
- Bivalent HPV L1 protein (types 16, 18)
- Presentation
- 0.5 mL · suspension · intramuscular · females 9 to 45 years
- Live vaccine
- No
Age and suitability depend on the product, the person and the reason for vaccination. Use the planner for a starting point and confirm with the Care365 clinical team or doctor.
Official product information
Use the DIN to confirm this exact product in Health Canada's Drug Product Database.
Read product monograph (PDF) ↗
A listed product may not be stocked or publicly funded.
Dose schedules involving this product
These are Canadian Immunization Guide schedules associated with this DIN. The right schedule depends on age, health, prior doses and reason for vaccination.
| Schedule | Doses | Who it applies to |
|---|---|---|
| HPV (CERVARIX, bivalent) — three doses Three doses of bivalent HPV vaccine at months 0, 1 and 6. | 3 doses | CERVARIX (HPV2) is authorized for females 9 to 45 years of age. The 9-valent vaccine is the preferred product in Canada; use this schedule only when CERVARIX is the product actually given or the series was started on it. |
Pregnancy and breastfeeding
Family guidance on pregnancy: Can be offered in pregnancy; it is usually deferred until after, and a dose given before pregnancy was known is not a concern.
Family guidance on breastfeeding: Use if indicated.
This guidance applies to the vaccine family. Confirm this product's details in the monograph and with your clinician. Immunization in pregnancy and breastfeeding: Canadian Immunization Guide — Chapter updated August 2026.
Sources and next steps
- Human papillomavirus (HPV) vaccines: Canadian Immunization Guide — Chapter revised July 2024
- Health Canada product record
General information only. A suggested date is not an appointment or a prescription; the Care365 clinical team or doctor confirms what you need. Clinical rules reviewed on 2026-09-27.
Review with Care365